Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:51:55.995Z.
Calculation as of: 2026-10-06T18:51:55.995Z.
Quote observation: 2026-10-06T18:47:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc2e94c8beea8e322b310e9b25a1b89028fd55b2fc6a2790cf1d230843e32158
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Incannex Healthcare Limited
Market Cap
$37.73M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.98M
Free Cash Flow Yield
N/A
TTM Avg
18.27%
3Y Avg
9.27%
5Y Avg
7.40%
Market Cap
$36.85M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.31M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.15M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.71M
Free Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.73M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $38.11M | N/A | 4.03% | 3.27% | 3.27% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.61M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.98M | N/A | 18.27% | 9.27% | 7.40% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.85M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.31M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $35.71M | N/A | 0.20% | 0.20% | 0.20% |
| DocGo Inc. (DCGO)vs › | $35.56M | N/A | 46.18% | 39.12% | 25.79% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
